SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 13
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO
RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. 1)
ADVANCED MEDICAL OPTICS, INC.
--------------------------------------------------------------------------------
(Name of Issuer)
Shares of Common Stock, par value $.01 per share
--------------------------------------------------------------------------------
(Title of Class of Securities)
00763M108
--------------------------------------------------------------------------------
(CUSIP Number)
October 9, 2002
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
1
-------------------- --------------------
CUSIP No. 00763M108 13G/A
-------------------- --------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Greenlight Capital, L.L.C.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
5 SOLE VOTING POWER
3,120,000
-------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY 0
OWNED BY -------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING
PERSON WITH 3,120,000
-------------------------------------------------
8 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,120,000
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES* [ ]
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
10.9% **
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
CO
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT
**SEE ITEM 4(b).
2
-------------------- --------------------
CUSIP No. 00763M108 13G
-------------------- --------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
David Einhorn
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S. Citizen
--------------------------------------------------------------------------------
5 SOLE VOTING POWER
3,120,000
-------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY 0
OWNED BY -------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING
PERSON WITH 3,120,000
-------------------------------------------------
8 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,120,000
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES* [ ]
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
10.9% **
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT
**SEE ITEM 4(b).
3
-------------------- --------------------
CUSIP No. 00763M108 13G
-------------------- --------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Jeffrey A. Keswin
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S. Citizen
--------------------------------------------------------------------------------
5 SOLE VOTING POWER
3,120,000
-------------------------------------------------
NUMBER OF 6 SHARED VOTING POWER
SHARES
BENEFICIALLY 0
OWNED BY -------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING
PERSON WITH 3,120,000
-------------------------------------------------
8 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,120,000
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES* [ ]
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
10.9% **
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT
**SEE ITEM 4(b).
4
AMENDMENT NO. 1 TO SCHEDULE 13G
This Amendment No. 1 to Schedule 13G (the "Schedule 13G"), relating to
shares of common stock of Advanced Medical Optics, Inc., a Delaware corporation
(the "Issuer"), is being filed with the Securities and Exchange Commission (the
"Commission") as an amendment to Schedule 13G filed with the Commission on
August 16, 2002. This Schedule 13G is being filed on behalf of Greenlight
Capital, L.L.C., a Delaware limited liability company ("Greenlight"), and Mr.
David Einhorn and Mr. Jeffrey A. Keswin, the principals of Greenlight,.
This Schedule 13G relates to shares of Common Stock of the Issuer
purchased by Greenlight for the account of (i) Greenlight Capital, L.P.
("Greenlight Fund"), of which Greenlight is the general partner, (ii) Greenlight
Capital Qualified, L.P. ("Greenlight Qualified"), of which Greenlight is the
general partner and (iii) Greenlight Capital Offshore, Ltd. ("Greenlight
Offshore"), to which Greenlight acts as investment advisor.
ITEM 4 OWNERSHIP.
(a) Greenlight and Messrs. Einhorn and Keswin are the beneficial
owners of 3,120,000 shares of Common Stock.
(b) Greenlight and Messrs. Einhorn and Keswin are the beneficial
owners of 10.9% of the outstanding shares of Common Stock.
This percentage is determined by dividing 3,120,000 by
28,723,512, the number of shares of Common Stock issued and
outstanding as of November 1, 2002, as reported in the
Issuer's quarterly report on Form 10-Q filed on November 8,
2002.
(c) Greenlight has the sole power to vote and dispose of the
3,120,000 shares of Common Stock beneficially owned by it. As
the principals of Greenlight, Messrs. Einhorn and Keswin may
direct the vote and disposition of the 3,120,000 shares of
Common Stock beneficially owned by Greenlight.
ITEM 10 CERTIFICATION.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are not
held for the purpose of or with the effect of changing or influencing
the control of the issuer of the securities and were not acquired and
are not held in connection with or as a participant in any transaction
having that purpose or effect.
EXHIBITS EXHIBIT 1
Joint Filing Agreement dated August 13, 2002, between Greenlight, David
Einhorn and Jeffrey A. Keswin.
5
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: November 14, 2002
Greenlight Capital, L.L.C.
By: /s/ JEFFREY A. KESWIN
-----------------------------------
JEFFREY A. KESWIN, Managing Member
/s/ DAVID EINHORN
----------------------------------------
David Einhorn
/s/ JEFFREY A. KESWIN
----------------------------------------
Jeffrey A. Keswin
6
EXHIBIT 1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) under the Securities Exchange Act of
1934, as amended, the undersigned agree to the joint filing on behalf of each of
them of a Statement on Schedule 13G (including any and all amendments thereto)
with respect to the Common Stock, par value $.01 per share, of Advanced Medical
Optics, Inc., and further agree that this Joint Filing Agreement shall be
included as an Exhibit to such joint filings.
The undersigned further agree that each party hereto is responsible for
the timely filing of such Statement on Schedule 13G and any amendments thereto,
and for the accuracy and completeness of the information concerning such party
contained therein; provided, however, that no party is responsible for the
accuracy or completeness of the information concerning any other party, unless
such party knows or has reason to believe that such information is inaccurate.
This Joint Filing Agreement may be signed in counterparts with the same
effect as if the signature on each counterpart were upon the same instrument.
IN WITNESS WHEREOF, the undersigned have executed this Agreement as of
November 14, 2002.
Greenlight Capital, L.L.C.
By: /s/ JEFFREY A. KESWIN
-----------------------------------
JEFFREY A. KESWIN, Managing Member
/s/ DAVID EINHORN
----------------------------------------
David Einhorn
/s/ JEFFREY A. KESWIN
----------------------------------------
Jeffrey A. Keswin
7